Screening and quantification of antipsychotic drugs in human brain tissue by liquid chromatography-tandem mass spectrometry: Application to postmortem diagnostics of forensic interest

Forensic Science International

Volumn 219, Issue 1-3, 2012, Pages 172-178

  Sampedro, M Carmen ^a   Unceta, Nora ^a   Gómez Caballero, Alberto ^a   Callado, Luis F ^a   Morentin, Benito ^b   Goicolea, M Aranzazu ^a   Meana, J Javier ^a   Barrio, Ramón J ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Basque Institute of Legal Medicine   (Spain)

Author keywords

Antipsychotics; Human brain tissue; Hybrid SPE Precipitation; LC MS MS

Indexed keywords

ACETONITRILE; AMISULPRIDE; AMMONIA; ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; FORMIC ACID; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; NORCLOZAPINE; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; SERTINDOLE; SULPIRIDE; THIORIDAZINE; TIAPRIDE; ZIPRASIDONE; ZUCLOPENTHIXOL;

ACCURACY; ARTICLE; AUTOPSY; CALIBRATION; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG SCREENING; ELUTION; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; PRECIPITATION; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 84861571773     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2012.01.002     Document Type: Article

References (39)

1. Freedman R., Schizophrenia New Engl. J. Med 2003, 349:1738-1749.
2. Healy D., Harris M., Tranter R., Gutting P., Austin R., Jones-Edwards G., Roberts A.P. Lifetime suicide rates in treated schizophrenia: 1875-1924 and 1994-1998 cohorts compared. Br. J. Psychiatry 2006, 188:223-228.
3. Rodda K.E., Dean B., McIntyre I.M., Drummer O.H. Brain distribution of selected antipsychotics in schizophrenia. Forensic Sci. Int. 2006, 157:121-130.
4. Rodda K.E., Drummer O.H. The redistribution of selected psychiatric drugs in post-mortem cases. Forensic Sci. Int. 2006, 164:235-239.
5. Kornhuber J., Wiltfang J., Riederer P., Bleich S. Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution. Eur. Arch. Psychiatr. Clin. Neurosci. 2006, 256:274-280.
6. Oertel R., Pietsch J., Arenz N., Zeitz S.G., Goltz L., Kirch W. Distribution of metoprolol tramadol, and midazolam in human autopsy material. J. Chromatogr. A 2011, 1218:4988-4994.
7. Merrick T.C., Felo J.A., Jenkins A.J. Tissue distribution of olanzapine in a postmortem case. Am. J. Forensic Med. Pathol. 2001, 22:270-274.
8. Ulrich S. Assay of olanzapine in human plasma by a rapid and sensitive gas chromatography-nitrogen phosphorus selective detection (GC-NPD) method: validation and comparison with high-performance liquid chromatography-coulometric detection. Ther. Drug Monit. 2005, 27:463-468.
9. Svendesen C.N., Bird E.D. HPLC with electrochemical detection to measure chlorpromazine, thioridazine and metabolites in human brain. Psychopharmacology 1986, 90:316-321.
10. Shimokawa Y., Akiyama H., Kashiyama E., Koga T., Miyamoto G. High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: application to the pharmacokinetic study. J. Chromatogr. B 2005, 821:8-14.
11. Titier K., Bouchet S., Pehourcq F., Moore N., Molimard M. High-performance liquid chromatographic method with diode array detection to identify and quantify atypical antipsychotics and haloperidol in plasma after overdose. J. Chromatogr. B 2003, 788:179-185.
12. Saracino M., Gandolfi O., Dall'Olio R., Albars L., Kenndler E., Raggi M. Determination of olanzapine in rat brain using high-performance liquid chromatography with coulometric detection and a rapid solid-phase extraction procedure. J. Chromatogr. A 2006, 1122:21-27.
13. Berna M., Shugert R., Mullen J. Determination of olanzapine in human plasma and serum by liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 1998, 33:1003-1008.
14. Shinozuka T., Terada M., Tanaka E. Solid-phase extraction and analysis of 20 antidepressant drugs in human plasma by LC/MS with SSI method. Forensic Sci. Int. 2006, 162:108-112.
15. Niederlander H.A.G., Koster E.H.M., Hilhorst M.J., Metting H.J., Eilders M., Ooms B., de Jong G.J. High throughput therapeutic drug monitoring of clozapine and metabolites in serum by on-line coupling of solid phase extraction with liquid chromatography-mass spectrometry. J. Chromatogr. B 2006, 834:98-107.
16. Maurer Hans H. Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology. Clin. Biochem. 2005, 38:310-318.
17. Saar E., Gerostamoulos D., Drummer Olaf H., Beyer J. Identification and quantification of 30 antipsychotics in blood using LC-MS/MS. J. Mass Spectrom. 2010, 45:915-925.
18. Wohlfarth A., Toepfner N., Hermanns-Clausen M., Auwarter V. Sensitive quantification of clozapine and its main metabolites norclozapine and clozapine-N-oxide in serum and urine using LC-MS/MS after simple liquid-liquid extraction work-up. Anal. Bioanal. Chem. 2011, 400:737-746.
19. Josefsson M., Roman M., Skogh E., Dahl M.L. Liquid chromatography/tandem mass spectrometry method for determination of olanzapine and N-desmethylolanzapine in human serum and cerebrospinal fluid. J. Pharm. Biomed. Anal. 2010, 53:576-582.
20. McClean S., O'Kane E.J., Smyth W.F. Electrospray ionization-mass spectrometric characterization of selected anti-psychotic drugs and their detection and determination in human hair samples by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2000, 740:141-157.
21. Nielsen M.K., Johansen S.S., Dalsgaard P.W., Linnet K. Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC-TOF-MS. Forensic Sci. Int. 2010, 196:85-92.
22. Shen M., Xiang P., Wu H., Shen B., Huang Z. Detection of antidepressant and antipsychotic drugs in human hair. Forensic Sci. Int. 2002, 126:153-161.
23. Zhang G., Terry A.V., Bartlett M.G. Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat brain tissue. J. Chromatogr. B 2007, 858:276-281.
24. Spina E., Avenoso A., Facciolà G.S.M.G., Ancione M.M.A.G., Ventimigli A., Perucca E. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics. Psychopharmacology 2000, 148:83-89.
25. Dinovo E.C., Bost R.O., Sunshine I., Gottschalk L.A. Distribution of thioridazie and its metabolites in human tissues and fluids obtained postmortem. Clin. Chem. 1978, 24:1828-1830.
26. Li K.-Y., Cheng Z.-N., Li X., Bai X.-L., Zhang B.-K., Wang F., Li H.-D. Simultaneous determination of quetipine and three metabolites in human plasma by LC-ESI-MS. Acta Pharmacol. Sin. 2004, 25:110-114.
27. Higashi Y., Kitahara M., Fujii Y. Simultaneous analysis of haloperidol, its three metabolites and two other butyrophenone-type neuroleptics by high performance liquid chromatography with dual ultraviolet detection. Biomed. Chromatogr. 2006, 20:166-172.
28. Flanagan R.J., Yusufi B., Barnes T.R.E. Comparability of whole-blood and plasma clozapine and norclozapine concentrations. Br. J. Clin. Pharmacol. 2003, 56:135-138.
29. Mercolini L., Mandrioli R., Iannello C., Matrisciano F., Nicoletti F., Raggi M.A. Simultaneous analysis of diazepam and its metabolites in rat plasma and brain tissue by HPLC-UV and SPE. Talanta 2009, 80:279-285.
30. Richardson D., Ortori C.A., Chapman V., Kendall D.A., Barrett D.A. Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. Anal. Biochem. 2007, 360:216-226.
31. Barker S.A., Littlefield-Chabaud M.A., David C. Distribution of the hallucinogens N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine in rat brain following intraperitoneal injection: application of a new solid-phase extraction LC-APcI-MS-MS-isotope dilution method. J. Chromatogr. B 2001, 751:37-47.
32. Emma B., Britt J., Margareta H.-U., Ulrika S.S.H. The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue. Rapid Commun. Mass Spectrom. 2004, 18:2565-2576.
33. FDA Guidance for Industry: Bioanalytical Method Validation 2001, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine, URL http://www.fda.gov/cder/guidance/index.htm.
34. Peters F.T., Drummer O.H., Musshoff F. Validation of new methods. Forensic Sci. Int. 2007, 165:216-224.
35. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal. Chem. 1998, 70:882-889.
36. Kornhuber J., Schultz A., Wiltfang J., Meineke I., Gleiter C.H., Zöchling R., Boissl K.W., Leblhuber F., Riederer P. Persistence of haloperidol in human brain tissue. Am. J. Psychiatry 1999, 156:885-890.
37. Hasselstrøm J., Linnet K. Ther. Drug Monit. 2004, 26:486-491.
38. Perry P.J., Miller D.D., Arndt S.V., Cadoret R.J. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am. J. Psychiatry 1991, 148:231-235.
39. Musshoff F., Padosch S., Steinborn S., Madea B. Fatal blood and tissue concentrations of more than 200 drugs. Forensic Sci. Int. 2004, 142:161-210.